Strategi Penurunan Stigma Masyarakat Terhadap Penyakit Tuberkolosis Menuju Eliminasi Tb 2030 Metode Systematic Literature Review (SLR)
Main Article Content
Abstract
Tuberkulosis (TB) tetap menjadi tantangan kesehatan masyarakat global, dengan sekitar 10 juta kasus dan 1,5 juta kematian yang dilaporkan pada tahun 2021, serta stigma yang signifikan terhadap penderita yang menghambat akses layanan kesehatan dan efektivitas pengobatan. Penelitian ini bertujuan untuk menganalisis strategi penurunan stigma di masyarakat terhadap TB melalui pendekatan Systematic Literature Review (SLR), sebagai langkah penting dalam mendukung upaya eliminasi TB pada tahun 2030. Metodologi penelitian ini menggunakan pendekatan Systematic Literature Review (SLR), yang mencakup pengumpulan dan analisis data dari artikel yang relevan danterbit antara 2016-2024. Protokol PRISMA diadopsi untuk mengidentifikasi, menyaring, dan menginclusi literatur, serta analisis tematik digunakan untuk mengidentifikasi dan menyoroti tema penting dalam data yang terkumpul. Hasil penelitian menunjukkan bahwa dari 153 artikel yang ditemukan, hanya 27 artikel yang relevan dan sesuai dengan subjek stigma tuberkulosis, dengan puncak publikasi terjadi pada tahun 2016. Analisis literatur menyoroti pentingnya pendekatan multidimensional dalam strategi penurunan stigma, termasuk peningkatan layanan kesehatan, edukasi masyarakat, dan keterlibatan komunitas. Untuk mencapai eliminasi tuberkulosis pada tahun 2030, diperlukan tindakan lintas sektor yang mengatasi hambatan sosial dan ekonomi, serta meningkatkan akses terhadap diagnosis dan perawatan.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
References
Al Abri, S., Kasaeva, T., Migliori, G. B., Goletti, D., Zenner, D., Denholm, J., & Petersen, E. (2020). Tools to implement the World Health Organization End TB Strategy: Addressing common challenges in high and low endemic countries. International Journal of Infectious Diseases, 92, S60-S68.
Arinaminpathy, N., Mandal, S., Bhatia, V., McLeod, R., Sharma, M., Swaminathan, S., & Singh, P. K. (2019). Strategies for ending tuberculosis in the South-East Asian Region: A modelling approach. Indian Journal of Medical Research, 149(4), 517-527.
Arinaminpathy, N., Mukadi, Y. D., Bloom, A., Vincent, C., & Ahmedov, S. (2023). Meeting the 2030 End TB goals in the wake of COVID-19: a modelling study of countries in the USAID TB portfolio. PLOS Global Public Health, 3(10), e0001271.
Behera, D., Pannu, V. P., & Behera, R. K. (2020). National TB Elimination Programme–Can it end TB in India by 2025: An appraisal. The Indian Journal of Chest Diseases and Allied Sciences, 62, 203-27.
Brown, J., Capocci, S., Smith, C., Morris, S., Abubakar, I., & Lipman, M. (2015). Health status and quality of life in tuberculosis. International Journal of Infectious Diseases, 32, 68-75.
Chakaya, J. M., Harries, A. D., & Marks, G. B. (2020). Ending tuberculosis by 2030—pipe dream or reality?. International Journal of Infectious Diseases, 92, S51-S54.
Chen, X., Xu, J., Chen, Y., Wu, R., Ji, H., Pan, Y., & Zhou, L. (2021). The relationship among social support, experienced stigma, psychological distress, and quality of life among tuberculosis patients in China. Scientific Reports, 11(1), 24236.
De Weger, E., Van Vooren, N., Luijkx, K. G., Baan, C. A., & Drewes, H. W. (2018). Achieving successful community engagement: a rapid realist review. BMC health services research, 18, 1-18.
Falzon, D., Timimi, H., Kurosinski, P., Migliori, G. B., Van Gemert, W., Denkinger, C., & Raviglione, M. C. (2016). Digital health for the End TB Strategy: developing priority products and making them work. European Respiratory Journal, 48(1), 29-45.
Fletcher, H. A., & Schrager, L. (2016). TB vaccine development and the End TB Strategy: importance and current status. Transactions of the Royal Society of Tropical Medicine and Hygiene, 110(4), 212-218.
Gomes, M. G. M., Barreto, M. L., Glaziou, P., Medley, G. F., Rodrigues, L. C., Wallinga, J., & Squire, S. B. (2016). End TB strategy: the need to reduce risk inequalities. BMC infectious diseases, 16, 1-4.
Harries, A. D., Lin, Y., Kumar, A. M., Satyanarayana, S., Takarinda, K. C., Dlodlo, R. A., & Olliaro, P. (2018). What can National TB Control Programmes in low-and middle-income countries do to end tuberculosis by 2030?. F1000Research, 7.
Indarwati, S. K. M., Agustina, N. W., Wahyuningsih, A., S., Marasabessy, N. B., & Ismarina, S.(2024). Kesehatan Masyarakat. CV Rey Media Grafika.
John, C. A. (2019). Realizing the World Health Organization’s end TB strategy (2016–2035): how can social approaches to tuberculosis elimination contribute to progress in Asia and the Pacific?. Tropical medicine and infectious disease, 4(1), 28.
Kane, J. C., Elafros, M. A., Murray, S. M., Mitchell, E. M., Augustinavicius, J. L., Causevic, S., & Baral, S. D. (2019). A scoping review of health-related stigma outcomes for high-burden diseases in low-and middle-income countries. BMC medicine, 17, 1-40.
Krishnamoorthy, Y., Nagarajan, R., Rajaa, S., Majella, M. G., Murali, S., & Jayaseelan, V. (2021). Progress of South East Asian Region countries towards achieving interim End TB strategy targets for TB incidence and mortality: a modelling study. Public Health, 198, 9-16.
Kunii, O., Yassin, M. A., & Wandwalo, E. (2016). Investing to end epidemics: the role of the Global Fund to control TB by 2030. Transactions of The Royal Society of Tropical Medicine and Hygiene, 110(3), 153-154.
Ledesma, J. R., Ma, J., Zhang, M., Basting, A. V., Chu, H. T., Vongpradith, A., & Fagbamigbe, A. F. (2024). Global, regional, and national age-specific progress towards the 2020 milestones of the WHO End TB Strategy: a systematic analysis for the Global Burden of Disease Study 2021. The Lancet Infectious Diseases.
Li, J., Chung, P. H., Leung, C. L., Nishikiori, N., Chan, E. Y., & Yeoh, E. K. (2017). The strategic framework of tuberculosis control and prevention in the elderly: a scoping review towards End TB targets. Infectious diseases of poverty, 6(03), 16-27.
Long, Q., Guo, L., Jiang, W., Huan, S., & Tang, S. (2021). Ending tuberculosis in China: health system challenges. The Lancet Public Health, 6(12), e948-e953.
Moscibrodzki, P., Enane, L. A., Hoddinott, G., Brooks, M. B., Byron, V., Furin, J., & Chiang, S. S. (2021). The impact of tuberculosis on the well-being of adolescents and young adults. Pathogens, 10(12), 1591.
No, P. (2024). Short Overview of The Burden of Tuberculosis. Clinical Medicine and Health Research, 4(02).
Oh, K. H., Rahevar, K., Nishikiori, N., Viney, K., Choi, H., Biermann, O., & Khang, D. X. (2018). Action towards universal health coverage and social protection for tuberculosis care and prevention: Workshop on the End TB Strategy Pillar 2 in the Western Pacific Region 2017.
Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., & Moher, D. (2021). The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. bmj, 372.
Pan, Z., Zhang, J., Bu, Q., He, H., Bai, L., Yang, J., & Lyu, J. (2020). The gap between global tuberculosis incidence and the first milestone of the WHO end tuberculosis strategy: an analysis based on the global burden of disease 2017 database. Infection and Drug Resistance, 1281-1286.
Pandey, B. D., Tun, M. M. N., Shah, Y., Suzuki, Y., & Morita, K. (2023). Ending tuberculosis by 2030: understanding the transmission. The Lancet Regional Health–Western Pacific, 38.
Paul, S., Akter, R., Aftab, A., Khan, A. M., Barua, M., Islam, S., & Sarker, M. (2015). Knowledge and attitude of key community members towards tuberculosis: mixed method study from BRAC TB control areas in Bangladesh. BMC public health, 15, 1-8.
Pedrazzoli, D., Borghi, J., Viney, K., Houben, R. M. G. J., & Lönnroth, K. (2019). Measuring the economic burden for TB patients in the End TB Strategy and Universal Health Coverage frameworks. The International Journal of Tuberculosis and Lung Disease, 23(1), 5-11.
Petersen, E., Blumberg, L., Wilson, M. E., & Zumla, A. (2017). Ending the Global Tuberculosis Epidemic by 2030—The Moscow declaration and achieving a major translational change in delivery of TB healthcare. International Journal of Infectious Diseases, 65, 156-158.
Powell, I., Siraj, A., & Kurian, C. (2024). The Effects of Stigma Against HIV and Tuberculosis on Healthcare-Seeking Behavior Among Tibetan Refugees in Dharamshala, India. Undergraduate Journal of Public Health, 8.
Rahevar, K., Fujiwara, P. I., Ahmadova, S., Morishita, F., & Reichman, L. B. (2018). Implementing the End TB Strategy in the Western Pacific region: translating vision into reality. Respirology, 23(8), 735-742.
Ramon-Pardo, P., Del Granado, M., Gerger, A., Canela Soler, J., Mir, M., Armengol, R., & Rodriguez, R. (2009). Epidemiology of tuberculosis in the Americas: the Stop TB strategy and the millennium development goals. The International journal of tuberculosis and lung disease, 13(8), 969-975.
Raviglione, M., & Sulis, G. (2016). Tuberculosis 2015: Burden, Challenges and Strategy for Control and Elimination. Infectious disease reports, 8(2), 6570. https://doi.org/10.4081/idr.2016.6570
Sachdeva, K. S., & Mase, S. R. (2019). The end TB strategy for India. Indian Journal of Tuberculosis, 66(1), 165-166.
Souza, M. D. R., Paz, W. S. D., Sales, V. B. D. S., Jesus, G. F. H. D., Tavares, D. D. S., Lima, S. V. A., & Bezerra-Santos, M. (2022). Impact of the COVID-19 pandemic on the diagnosis of tuberculosis in Brazil: is the WHO End TB strategy at risk?. Frontiers in pharmacology, 13, 891711.
Suthar, A. B., Zachariah, R., & Harries, A. D. (2016). Ending tuberculosis by 2030: can we do it?. The international journal of tuberculosis and lung disease, 20(9), 1148-1154.
Zhang, H., Liu, X., Xu, C., Hu, D., Li, X., Li, T., Zhao, Y., Chen, M., & Liu, J. (2020). Guiding Tuberculosis Control Through the Healthy China Initiative 2019-2030. China CDC weekly, 2(49), 948–950. https://doi.org/10.46234/ccdcw2020.236